The surge of interest surrounding GLP‑1 receptor agonists and related metabolic therapies has rapidly transformed the landscape of obesity medicine....
Read moreThe modern enthusiasm surrounding biomarker testing and preventive diagnostics reflects a growing conviction that disease can be intercepted long before...
Read moreTestosterone replacement therapy and broader hormone optimization have migrated from endocrinology clinics into subscription platforms, influencer podcasts, and venture-backed telehealth...
Read moreThe gut-brain axis—once a niche topic in neurogastroenterology and mucosal immunology—is now a staple of TikTok explainers and supplement...
Read moreThe United States fertility rate has declined to historic lows, falling below replacement level for more than a decade. According...
Read moreAttention-deficit/hyperactivity disorder has moved from the margins of pediatric psychiatry into the center of educational policy and pharmaceutical logistics. Over...
Read moreHealthy aging has emerged as one of the most persistently discussed healthcare themes across clinical conferences, investment forums, and consumer...
Read moreAcross health systems, Medicaid waivers, and employer-sponsored benefit designs, “food as medicine” initiatives are moving from demonstration projects to embedded...
Read moreBreathwork seminars sell out in corporate conference rooms. Cold plunge tubs now sit beside Pelotons in executive homes. “Regulating the...
Read moreEmergency and seasonal preparedness for influenza, respiratory syncytial virus, and COVID has become a standing agenda item for hospital executives,...
Read moreTelehealth expansion, virtual intensive care units, and remote neonatal and specialty nursing programs have moved from pilot status to operating...
Read moreThe wellness industry did not wait for healthcare reform; it built a parallel operating system and invited the public to...
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy